業績

HOME > 業績 > 2025年
  • 原著 Enrichment of Porphyromonas gingivalis in colonic mucosa-associated microbiota and its enhanced adhesion to epithelium in colorectal carcinogenesis: Insights from in vivo and clinical studies
    Motosugi S, Takahashi N, Mineo S, Sato K, Tsuzuno T, Aoki-Nonaka Y, Nakajima N, Takahashi K, Sato H, Miyazawa H, Taniguchi K, Terai S, Tabeta K.
    PLoS One. 2025 Mar 25;20(3):e0320383. doi: 10.1371/journal.pone.0320383. eCollection 2025.
  • 総説・解説 Recommendations for the safe implementation of intravenous administration of mesenchymal stromal cells
    Terai S, Ezoe S, Mano K, Matsuzaki Y, Sato Y, Yamahara K, Okano H.
    Regen Ther. 2025 Mar 19;29:171-176. doi: 10.1016/j.reth.2025.01.024. eCollection 2025 Jun.
  • 原著 Hepatitis B virus infection and its treatment in Eastern Ethiopia
    Kanda T, Sasaki-Tanaka R, Tsuchiya A, Terai S.
    World J Hepatol. 2025 Jan 27;17(1):99209. doi: 10.4254/wjh.v17.i1.99209.
  • 総説・解説 間葉系幹細胞投与による胆管再生効果の検討
    木村 成宏、寺井 崇二
    新潟県医師会報 899号 Page8-9(2025.02)
  • 総説・解説 【知っておきたい他科・他臓器疾患の基礎知識(II)】消化器内科 好酸球性消化管疾患(EGIDs)
    川田 雄三, 佐藤 裕樹, 高橋 一也, 田中 裕登, 柴田 理, 小島 雄一, 中島 尚, 冨永 顕太郎, 五十嵐 聡, 林 和直, 水野 研一, 寺井 崇二
    呼吸器内科 47巻2号 Page113-117(2025.02)
  • 総説・解説 今月の話題 肝臓リハビリテーションの現状と今後の展望
    寺井 崇二
    Medical Practice 42巻2号 Page308-310(2025.02)
  • 症例報告 A Case of Type 2 Autoimmune Pancreatitis Suggesting Two Potential Disease Activity Markers
    Natsui K, Yoshikawa S, Kagata A, Horibata Y, Usuda H, Takeuchi M, Terai S.
    Gastro Hep Adv. 2025 Feb 1;4(6):100635. doi: 10.1016/j.gastha.2025.100635. eCollection 2025.
  • 原著 Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis
    Sakamaki A, Yokoyama K, Yamazaki H, Wakabayashi T, Kojima Y, Tominaga K, Tsuchiya A, Kamimura K, Yokoyama J, Terai S.
    J Clin Med. 2025 Feb 23;14(5):1491. doi: 10.3390/jcm14051491.
  • 総説・解説 Pruritus in Chronic Cholestatic Liver Diseases, Especially in Primary Biliary Cholangitis: A Narrative Review
    Kanda T, Sasaki-Tanaka R, Kimura N, Abe H, Yoshida T, Hayashi K, Sakamaki A, Yokoo T, Kamimura H, Tsuchiya A, Kamimura K, Terai S.
    Int J Mol Sci. 2025 Feb 22;26(5):1883. doi: 10.3390/ijms26051883.
  • 原著 Aligning cellular and molecular components in age-dependent tertiary lymphoid tissues of kidney and liver
    Toriu N, Sato Y, Kamimura H, Yoshikawa T, Tanaka M, Yamamoto S, Fukuma S, Hattori M, Terai S, Yanagita M.
    PLoS One. 2025 Feb 27;20(2):e0311193. doi: 10.1371/journal.pone.0311193. eCollection 2025.
  • 原著 Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study
    Kawaratani H, Namisaki T, Kondo Y, Tatsumi R, Kawabe N, Tanabe N, Sakamaki A, Hoshikawa K, Uchida Y, Endo K, Kawaguchi T, Oikawa T, Ishizu Y, Hige S, Takami T, Terai S, Ueno Y, Mochida S, Koike K, Yoshiji H.
    J Clin Med. 2025 Feb 18;14(4):1358. doi: 10.3390/jcm14041358.
  • 原著 Human placental extract improves liver cirrhosis in mice with regulation of macrophages and senescent cells
    Ishikawa N, Watanabe Y, Maeda Y, Yoshida T, Kimura N, Abe H, Sakamaki A, Kamimura H, Yokoo T, Kamimura K, Tsuchiya A, Terai S.
    Regen Ther. 2025 Feb 4;28:509-516. doi: 10.1016/j.reth.2025.01.017. eCollection 2025 Mar.
  • その他 Combination therapies with immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma with major vascular invasion
    Kanda T, Sasaki-Tanaka R, Terai S.
    Hepatol Int. 2025 Feb 8. doi: 10.1007/s12072-025-10784-9.
  • その他 Eicosatetraynoic Acid Regulates Profibrotic Pathways in an Induced Pluripotent Stem Cell-Derived Macrophage-Human Intestinal Organoid Model of Crohn’s Disease.
    Jurickova I, Tominaga K, et al.
    J Crohns Colitis. 2025;19(2):jjae139.
  • 総説・解説 代謝機能障害関連脂肪性肝疾患(MASLD)
    坂牧僚
    新潟県医師会報 2025, 第899号, 18-21